0001127602-13-035380.txt : 20131220 0001127602-13-035380.hdr.sgml : 20131220 20131220163154 ACCESSION NUMBER: 0001127602-13-035380 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131218 FILED AS OF DATE: 20131220 DATE AS OF CHANGE: 20131220 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARIAD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000884731 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 223106987 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 26 LANDSDOWNE ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 6174940400 MAIL ADDRESS: STREET 1: 26 LANDSDOWNE CITY: CAMBRIDGE STATE: MA ZIP: 02139 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BERSTEIN DAVID L CENTRAL INDEX KEY: 0001242986 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36172 FILM NUMBER: 131291929 MAIL ADDRESS: STREET 1: C/O ARIAD PHARMACEUTICALS INC STREET 2: 26 LANDSDOWNE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2013-12-18 0000884731 ARIAD PHARMACEUTICALS INC ARIA 0001242986 BERSTEIN DAVID L C/O ARIAD PHARMACEUTICALS, INC. 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 1 Senior VP, Chief IP Officer Common Stock 2013-12-18 4 M 0 9000 0 A 225898 D Common Stock 2013-12-19 4 S 0 4500 5.14 D 221398 D Shares were acquired upon vesting of performance stock units awarded on March 20, 2012. Represents shares sold to satisfy withholding tax requirements. Shares were sold pursuant to a 10b5-1 plan adopted by the reporting person on December 21, 2012. /s/Edward M. Fitzgerald, Attorney-in-Fact 2013-12-20